3 Nuclear Stocks to Buy With $2,000 After One Fell 83%

Constellation Energy raised 2026 adjusted EPS guidance to $11.50–$12.50 after its nuclear fleet generated 44,160 GWh in Q2 and operating earnings rose 34% YoY to $2.55/share, supported by 15–20 year power purchase agreements. Cameco reiterated long-term uranium contracting with average deliveries of 28+ million pounds per year over the next five years, though Q2 earnings declined as Westinghouse stake earnings fell versus the prior year. In contrast, NuScale’s only NRC-certified small modular reactor design still produced just $75,000 in Q2 revenue and widened its net loss to $50.1 million, underscoring that approvals have not yet translated into paid orders.

Analysis

The market is still treating “nuclear” as one trade, but the cash-flow split matters more than the technology slogan. The cleanest beneficiaries are the names already converting scarcity into contracted economics: CEG gets the fastest pass-through from tightening baseload supply, while CCJ is the lower-beta way to own the fuel-cycle shortage without paying for perfect commodity pricing. Second-order, every incremental long-dated power contract should pressure merchant gas and uncontracted power assets more than it helps early-stage reactor design.

SMR is a different instrument entirely: a regulated design is not a business until a utility signs, finances, and starts building. That leaves it exposed to a classic “good news, no monetization” de-rating cycle over the next 1-3 quarters if there are no definitive orders; the real reversal catalyst is not another approval, but a named project with financing and offtake. The company’s cash gives it time, but not immunity from dilution risk if commercialization slips into 2027.

Contrarian takeaway: the consensus may be overstating upside beta to SMR and understating how much of the nuclear re-rating is already embedded in CEG/CCJ. The best risk/reward is to own operating cash flows and contracted pounds, not a pre-revenue option on future buildout. What would falsify that view is either a material drop in forward power prices / outage-driven guidance cuts for CEG, or a meaningful deterioration in contracted uranium volumes or pricing discipline for CCJ.

Key Decisions for Investors

• Long CEG on pullbacks over the next 1-3 weeks; target a 10-15% move if PPAs and earnings revisions continue, but cut risk if power prices soften or guidance is revised down.
• Long CCJ as a 6-12 month lower-volatility nuclear exposure; risk/reward is better than SMR because the cash flows are already contracted, but thesis breaks if long-term uranium contracting slows or realized pricing weakens.
• Short SMR or use a bear put spread into any strength over the next 1-3 months; the setup is attractive because the stock still depends on order conversion, not approvals, and another quarter without a definitive utility contract would likely keep pressure on the multiple.
• Pair trade: long CEG / short SMR for 1-3 months to isolate ‘cash flow now vs. option value later’; this is the cleanest expression if the market keeps bidding the nuclear theme indiscriminately.
• Set an alert on SMR for a signed TVA/ENTRA1-style project announcement; that is the first real falsifier for the short case and would require covering quickly if financing and offtake are both confirmed.